Biotronik touts doctors’ survey responses for Magmaris drug-eluting scaffold

Biotronik touted data today from its Magnesium 1,000 program, which provided doctors with an early post-market opportunity to evaluate the company’s new resorbable Magmaris magnesium scaffold. More than 98% of physicians reported that the scaffolds successfully deployed, according to the data, and that it performed well compared to the leading polymeric scaffold, Biotronik said.

The program began in June last year and included more than 400 physicians in 237 hospitals across 32 countries. Biotronik asked the participating physicians to rate their personal experiences of acute performance with Magmaris and to compare their experiences with the leading polymeric scaffold for each case.

Get the full story at our sister site, Drug Delivery Business News.

The post Biotronik touts doctors’ survey responses for Magmaris drug-eluting scaffold appeared first on MassDevice.

from MassDevice http://ift.tt/2odrZAs